Skip to main content
. 2020 Oct 24;10(1):121–147. doi: 10.1007/s40120-020-00221-4

Fig. 1.

Fig. 1

Disposition of patients with schizophrenia. *Due to a lack of drug supply at study centres in Argentina and Brazil, patients who had not completed the DB trial had the option of enrolling in the OLE study or discontinuing the study. DB double-blind, OLE open-label extension